In 2009, Hastings et al. reported that a tetracycline-like antibiotic, PTK-SMA1, blocked exon 7 skipping of SMN2 in fibroblasts from patients with SMA and in liver from SMA-affected mice [114]. Here, SMN2 is linked to proximal spinal muscular atrophy.